GlassScriptPhysician profile
Evan Caruso
NPI 1255727723
$5,955.07
in general payments reported to CMS, 2019-2025
29 companies · $1,418 in 2025
The $1,418 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $408 · 2020: $123 · 2021: $687 · 2022: $198 · 2023: $2,065 · 2024: $1,055 · 2025: $1,418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,739 · Travel and Lodging: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,738.52 |
| Travel and Lodging | $800.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,396.90 | 2023-2025 | Optis, Ultreon, Coroflow |
| Pfizer INC. | $372.01 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $366.50 | 2023-2025 | |
| Abiomed | $331.41 | 2024-2025 | Impella, Abiraterone Acetate |
| Shockwave Medical, INC | $322.02 | 2025 | |
| Cardiovascular Systems INC. | $291.34 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $214.13 | 2019-2025 | Farxiga, Wainua |
| E.R. Squibb & Sons, L.L.C. | $182.35 | 2019-2025 | Eliquis, Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $175.54 | 2024-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $157.65 | 2022-2024 | Verquvo |
| Penumbra, INC. | $139.39 | 2021 | |
| Chiesi USA, INC. | $132.02 | 2021 | |
| Medtronic, INC. | $120.22 | 2021 | |
| Boston Scientific Corporation | $119.33 | 2019 | |
| Preventice Services, LLC | $110.64 | 2020 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $83.16 | 2024 | Arcalyst |
| Reflow Medical INC | $65.20 | 2023-2024 | |
| Inari Medical, INC. | $65.11 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Philips North America LLC | $62.95 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $48.47 | 2019-2025 | Evkeeza, Dupixent |
| Stryker Corporation | $37.26 | 2025 | Artix Mt, Flowtriever |
| Amgen INC. | $30.22 | 2019-2025 | Repatha |
| Heartflow, INC. | $26.11 | 2025 | |
| Coastal Medical Technologies LLC | $23.39 | 2023 | |
| Alnylam Pharmaceuticals INC. | $20.33 | 2024 | Onpattro |
| Biosense Webster, INC. | $19.70 | 2025 | Nuvision Ice Catheter |
| Lexicon Pharmaceuticals, INC. | $15.37 | 2023 | Inpefa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.50 | 2023 | Jardiance |
| Kestra Medical Technology Services, INC. | $12.85 | 2023 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Caruso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.